| 词条 | Health technology assessment |
| 释义 |
PurposeHealth technology assessment is intended to provide a bridge between the world of research and the world of decision-making.[4] HTA is an active field internationally and has seen continued growth fostered by the need to support management, clinical, and policy decisions. It has also been advanced by the evolution of evaluative methods in the social and applied sciences, including clinical epidemiology and health economics. Health policy decisions are becoming increasingly important as the opportunity costs from making wrong decisions continue to grow.[5] HTA is now also used in assessment of innovative medical technologies like telemedicine e.g. by use of the Model for assessment of telemedicine (MAST). Health technology can be defined broadly as: {{Quote|Any intervention that may be used to promote health, to prevent, diagnose or treat disease or for rehabilitation or long-term care. This includes the pharmaceuticals, devices, procedures and organizational systems used in health care.[6]}}HistoryThe growth of HTA internationally can be seen in the expanding membership of the International Network of Agencies for Health Technology Assessment (INAHTA), a non-profit umbrella organization established in 1993. Organizations and individuals involved in HTA research are also affiliated with societies such as the international societies HTAi and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).[7] An international Masters program in health technology assessment and management, ULYSSES, is also offered. Health Technology Assessment by countryUnited KingdomThe United Kingdom's National Institute for Health Research runs several research programmes which may be viewed as falling into the realm of Health Technology Assessment. Of particular note is the NIHR Health Technology Assessment programme, its longest running, which undertakes both conventional HTA in the form of Evidence Synthesis and modelling, and evidence generation with a large portfolio of pragmatic RCTs and cohort studies. Also in the UK, the Multidisciplinary Assessment of Technology Centre for Healthcare carries out HTA in collaboration with the health service, the NHS and various industrial partners. MATCH is organised into four themes addressing key HTA topics including Health Economics, Tools for Industry, User Needs and Procurement and Supply chain. See also
References1. ^{{cite web | author=INAHTA (International Network of Agencies for Health Technology Assessment) | title=HTA Glossary.net | url=http://htaglossary.net/health+technology+assessment+%28HTA%29 | date=Jun 1, 2015 | publisher=INAHTA}} 2. ^{{cite journal |vauthors=Luce BR, etal | title=. EBM, HTA, and CER: clearing the confusion | journal=Milbank Q | date=2010 | volume=88 | pages=256–76 | pmid=20579285 | pmc=2980346 | issue=2 | doi=10.1111/j.1468-0009.2010.00598.x}} 3. ^EUnetHTA (European network for Health Technology Assessment) https://www.eunethta.eu/about-eunethta/ 4. ^Battista, RN: The scientific basis of health services. BMJ Publishing Group, 1996. 5. ^{{cite journal | author=Menon D.| title=The internationalization of heath technology assessment | journal= International Journal of Technology Assessment in Health Care| date=1996 | volume=12 | pages=45–51 | pmid=8690561 | last2=Marshall | first2=D | issue=1| doi=10.1017/S0266462300009375 }} 6. ^{{cite web | author=INAHTA (International Network of Agencies for Health Technology Assessment). | title=HTA glossary. | url=http://htaglossary.net/tiki-index.php?page=health%20technology | date=Oct 8, 2013 | publisher=HTAi}} 7. ^{{cite web |title=International Society for Pharmacoeconomics and Outcomes Research |url=https://www.ispor.org |website=ISPOR |accessdate=9 September 2018}} External links{{Prone to spam|date=September 2018}}{{Z148}}
4 : Impact assessment|Medical technology|Technology assessment|Life sciences industry |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。